IHA Daily Briefing: April 16

FDA: Pediatric Breathing Tube Shortage
IDPH Adopts Mandatory Newborn Hearing Testing
Illinois Diabetes Symposium May 14-15
Briefly Noted

FDA: Pediatric Breathing Tube Shortage
On Friday, the Food and Drug Administration (FDA) issued a statement regarding the temporary shortage of pediatric breathing tubes which it says is due to the temporary closure of the Sterigenics ethylene oxide medical device sterilization facility in Willowbrook.

“Despite best efforts to minimize the impact of the closures wherever possible, we have identified a medical device that is now in temporary shortage. Today [April 12], we are alerting health care professionals, parents and caregivers that there is a temporary shortage of a type of a tracheostomy tube manufactured by Smiths Medical,” said Jeff Shuren, M.D., director of the Center for Devices and Radiological, FDA. “I want to assure you that the FDA is working closely with the company to quickly resolve their sterilization challenges and bring these critical devices to the patients who need them as quickly as possible, which we anticipate will be made available again beginning the week of April 22.”

Specifically, the availability of Smiths Medical’s Bivona tracheostomy tubes have been impacted. During the temporary shortage, healthcare professionals who have patients urgently in need of a new Bivona tube should contact Smiths Medical directly to inquire about current inventory. Approximately 28,000 Bivona tracheostomy tubes are awaiting sterilization at an alternative facility.

IDPH Adopts Mandatory Newborn Hearing Testing
The Illinois Department of Public Health (IDPH) adopted rules (March 29 Illinois Register pages 3889-3944) to implement PA 99-0834, the Early Hearing Detection and Intervention Act. The adopted rules add requirements to Section 250.1830 – General Requirements for All Obstetric Departments.

Under these requirements, hospitals must:

  • Conduct bilateral hearing screening of each newborn infant prior to discharge unless medically contraindicated or the infant is transferred to another hospital before the hearing screening can be completed;
  • Report the results of the hearing screening to IDPH within seven days after screening; and
  • Refer the parents or guardians to a healthcare practitioner for follow-up care when there are no screening results or the infant does not pass the hearing screening in both ears at the same time. That referral, including the practitioner that the patient is being referred to, must be documented and reported to IDPH.

For those infants born outside a hospital, the newborn’s primary care provider is required to refer the patient to a hospital for the screening within 30 days after birth unless a different time period is medically indicated.

Illinois Diabetes Symposium May 14-15
IHA, along with the Illinois Dept. of Public Health (IDPH) and the Illinois Critical Access Hospital Network, is once again offering the Illinois Diabetes Symposium: Beyond Blood Sugars on May 14 and 15 in Springfield. This two-day symposium aims to increase knowledge among healthcare professionals in Illinois.

Key topics include:

  • Motivational interviewing to improve adherence;
  • Standards of care in diabetes;
  • Diabetes self-management business models;
  • Barriers impacting successful diabetes self-management;
  • Diabetes pharmacotherapy;
  • Plant-based eating;
  • Strategies for promoting behavior change; and
  • A special school nurse track on day two.

The cost is $99 for both days; $60 for one day. Nursing, pharmacy and dietary continuing education credits are available.

For more information, including the full agenda, guestroom block and registration link, click here.

Funding for this program is provided by the IDPH Improving the Health of Illinoisans through Chronic Disease Prevention (CDC-DP18-1815).

Briefly Noted
The U.S. Food and Drug Administration (FDA) reports that some people who use e-cigarettes, especially youth and young adults, are experiencing seizures following their use. While only 35 cases have been reported between 2010 and early 2019, the FDA says that many more may have occurred but not have been reported. The FDA is monitoring the issue and working on a scientific investigation.

April 16 is National Healthcare Decisions Day, designed to inspire, educate and empower the public and providers about the importance of advance care planning. Make sure your end-of-life care and wishes are known through an advanced directive.